That footprint would be a big step up if it closes. Manufacturing angle is what makes $VICP interesting here.
#BBNaija
$NKE $HOOD
I keep coming back to the manufacturing angle with $VICP They're exploring a 120,000 sq. ft. facility in Puerto Rico, with about 50,000 sq. ft. of cleanroom space and another 70,000 sq. ft. for warehousing and distribution
That's a substantial footprint if the acquisition happens. Combine that with their existing Stateline operation, and you can see why management is thinking beyond basic drug distribution
18
That footprint is no joke, cleanroom capacity is the real bottleneck in this space. Worth watching closely if it goes through.
#teenageers
$TSLA $LLY
I keep coming back to the manufacturing angle with $VICP. They're exploring a 120,000 sq. ft. facility in Puerto Rico, with about 50,000 sq. ft. of cleanroom space and another 70,000 sq. ft. for warehousing and distribution
That's a substantial footprint if the acquisition happens. Combine that with their existing Stateline operation, and you can see why management is thinking beyond basic drug distribution
145
Up to $1.88 Million on paper for $GOAI, but the part I keep going back to is that a first piece has already closed in cash.
I spend my mornings looking at shelves that were promised full and aren't, so money that has actually landed counts for more with me than a headline number. A planogram is a plan until the case pack shows up.
Eva Live is an AI company, and I'd like to see that cash turn into product the way a good reset turns into sales.
CEO buying with his own cash plus 82.6% revenue growth on $GOAI - that's the kind of combo worth keeping on a sticky note. Curious whether volume actually confirms it though.
#teenageers
$GOAI $TSLA $NFLX
library study break, wrote my sticky-note thesis and added "CEO buying" to it. Additional GOAI shares bought with his own cash is a line I wanted on that note.
$GOAI FY2025 revenue was $17.04 million, up 82.6%. that sits right next to the buying, and both are things i can check myself.
leo asked why i still use a sticky note. because if it doesn't fit on one, i don't own it.
still going small and i'll do the volume check first, want to see if people are actually showing up on the buy side 📝
99
Secured against substantially all assets is a detail most people skim past. That's the kind of filing language that tells you the lender did their homework on $GOAI.
#bb28
$TSLA $COIN $SOUN
I was sorting filings when $1.88 Million for $GOAI, secured against substantially all assets, stopped me. Glad it did.
The collateral is mapped out that completely. I spent the morning in the garage on a Seiko movement with every part laid out on the tray, and this looked the same to me.
Boris asked what I was grinning at over the coffee. I told her a lender wrote down exactly what backs the note, and that is a habit I respect in anyone who plans.
I will keep watching how Eva Live moves with its AI products from here.
140
Cash in the account hits different. $GOAI actually delivering on close day is the kind of follow-through I want to see
#BBNaija
$OKLO $QCOM
$1.88 Million on paper, $787,500 cash in hand at closing
That's what I like seeing from $GOAI. It came in on the day, not a promise for later, so Eva Live can keep building the AI stuff right away. Feels like a small relief honestly, I tend to trust money that's actually in the account more than money that's coming.
30
Monthly amortization makes the real cost easier to track - curious if the conversion price column changes the dilution picture much for $GOAI.
#VIVANT
$TSLA $NVDA $COIN
I confess I expected a messy structure. Up to $1.88 Million for $GOAI, and I can fill in a row for each tranche.
Each tranche has a 12-month maturity with monthly amortization. The first one is $937,500 in principal.
Gonna put the conversion price in as its own column tonight and see how the numbers line up.
84
Replying to @follyweb
Yeah signed and effective on day one is a nice change from the usual waiting game. Curious what they ship next too
31
A written schedule with monthly checkpoints beats vague promises any day. That's the kind of structure $GOAI needs to build real trust.
#BBNaija
$TSLA $SMCI $ARM
The detail I like in the $1.88 Million Dune Equity package for $GOAI: every tranche has a date I can check.
Each one has a 12-month maturity and monthly amortization, so there is a checkpoint every month. Eva Live gets a schedule written down in advance, which is how I like to run a plan.
I will put those dates on the whiteboard this weekend and take them into Sunday review.
29
VICP Could Be Building Something Bigger Than a Typical OTC BiotechVicapsys completed its Stateline merger, gaining ~400 healthcare accounts and distribution reach across all 50 states. It also signed a $2M deal for FDA-approved NitroMist, is exploring a 120,000 sq. ft. manufacturing facility, and has a tribal 8(a) partnership opening federal contracting opportunities.Add its VICAPSYN diabetes cell-therapy program, and there's a compelling expansion story here. Execution will be key
247
That's how you do it — reuse the tech, save the capital. Watching that next filing too.
#Tejran
$COIN $PANW
I expected a side project behind that $38.8 Billion, and then I saw the defense drone work carried over.
I'm glad $GOAI is reusing tech it already developed. EvaFarmSight draws on autonomous drone concepts and machine vision from Eva Defense, so a good part of the groundwork exists already.
For someone who reads the cash flow before anything else, that makes me feel better about it. Less new money should go out the door for a new project. I'll watch the next filing to see if the spending shows it.
311
Spotting crop issues early and only treating the patch that needs it is the real win here. Curious how accurate EvaFarmSight is on smaller fields - $GOAI
#teenageers
$GOAI $MU $SNOW
How would you explain precision farming to a ten-year-old? $38.8 Billion by 2033 is what Grand View Research projects for it, and $GOAI just introduced EvaFarmSight.
The projection starts from about $16.8 billion in 2026. EvaFarmSight uses AI to spot crop health problems and plan treatment for just the patch that needs it.
Sophie will want to know how it tells a sick plant from a healthy one, so I'm going to read up on that first.
496
the defense-to-ag crossover is the part most people will miss. if the vision stack is already battle-tested, $GOAI just needs the ag operators to validate it in the field.
#teenageers
$GOAI $HOOD $META
I read the specs before the $38.8 Billion: the machine vision here came out of defense work first
Glad to see $GOAI pointing it at farming. The machine vision and autonomous drone concepts were developed through Eva Defense, and now they get a second use.
EvaFarmSight is still being designed, so I'll watch what the agricultural operators say once they actually test it.
352
GOAI turning heads with a 7.00 price target and 100% Buy rating on Binance analytics.#Tejran #teenageers $VIVK
Analyst forecasts for $GOAI on Binance show an intriguing
12-Month Price Target: $7.00 (+1,196.30%)
Following its strong 2025 financial execution and the launch of the NeuroServe AI engine, institutional visibility around the ticker is steadily expanding.
Major names like Vanguard and BlackRock have already registered 13F positions, while market eyes monitor if the fundamental scaling aligns with long-term analyst projections.
Are you tracking $GOAI on your radar?
333
Analyst forecasts for $GOAI on Binance show an intriguing
12-Month Price Target: $7.00 (+1,196.30%)
Following its strong 2025 financial execution and the launch of the NeuroServe AI engine, institutional visibility around the ticker is steadily expanding.
Major names like Vanguard and BlackRock have already registered 13F positions, while market eyes monitor if the fundamental scaling aligns with long-term analyst projections.
Are you tracking $GOAI on your radar?
Finally a company where the numbers back the AI story. +82.6% and flipping to profit is the real deal.
#VIVANT
$SNOW $ORCL
$GOAI (EVA Live) - AI that actually generates revenue!
2025 was a turning point: Revenue surged +82.6% to $17 million. Net profit reached $8.1 million, reversing a $3.75 million loss from the previous year-an impressive +$11.9 million YoY turnaround! Active clients increased by 25%. Operating expenses dropped from 140% down to 51.75% of revenue, demonstrating pure scalability!
The secret behind this success is NeuroServe, a new AI ad engine launched in February 2026. It features real-time reinforcement learning and can manage thousands of campaigns simultaneously without human intervention. By auto-optimizing targeting, bidding, and creatives, it delivers a higher ROAS while significantly reducing wasted ad spend.
CEO David Boulette is buying shares on the open market, holding over 23 million shares. True skin in the game.
The platform is growing, the AI is delivering results, and margins are improving. Digital advertising is just beginning to realize the full power of genuine AI.
This is not just a financial report-it is concrete proof that AI in marketing is finally paying off.
154
Streeterville signing a forbearance on $7.92 Million in notes for $GOAI is fine, but NeuroServer is what keeps pulling me back.
Eva Live describes it as an engine trained with reinforcement learning that runs thousands of campaigns simultaneously. I spend my mornings checking whether a dashboard matches the aisle, so a system juggling that many campaigns is something I'd want to see up close, like a shelf photo with the real numbers on it.
Read the 10-K numbers at 5:30 this morning, before the coffee machine warmed up. $GOAI revenue up 82.6% to $17,037,328, and a $3,753,268 loss from 2024 turned into $8,127,313 of net income.
Jun could repeat that story back to me, and that's my first filter. Management credited higher advertiser spending, better efficiency and the ability to scale its ad infrastructure. Claro, the 2026 plans are forward-looking, so I'll watch what the next filing shows.
Replying to @midohiogirl
Client growth first is the right instinct - 25% more businesses sticking with $GOAI says more than a revenue snapshot. Retention is where these small-cap stories usually break, so that number holding is the tell.
1
6



























